Background: The t: slim X2™ insulin pump with Control-IQ® technology from Tandem
Diabetes Care is an advanced hybrid closed-loop system that was first commercialized in …

Abstract The incidence of Diabetes Mellitus is on the rise worldwide, which exerts enormous
health toll on the population and enormous pressure on the healthcare systems. Now …

Self-managing a chronic condition involves adapting management strategies to life's
continual change. Among these changes, moments of significant life transition can render …

Background Closed-loop insulin delivery systems are expected to become a standard
treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop …

Background The objective of this study was to evaluate the glycemic outcomes in children
and adolescents with Type 1 Diabetes (T1D) previously treated with Multiple Daily Injections …

OBJECTIVE The MiniMed 670G System is the first commercial hybrid closed-loop (HCL)
system for management of type 1 diabetes. Using data from adolescent and young adult …

Abstract A novel Model Predictive Control (MPC) law for the closed-loop operation of an
Artificial Pancreas (AP) to treat type 1 diabetes is proposed. The contribution of this paper is …

Objective: Zone model predictive control (MPC) has been proven to be an efficient approach
to closed-loop insulin delivery in clinical studies. In this paper, we aim to safely reduce mean …

Background and objective: Glycemic control, especially meal-related disturbance rejection,
has proven to be a major challenge for people with type 1 diabetes. In this manuscript, we …

Background: There is an unmet need for a modular artificial pancreas (AP) system for
clinical trials within the existing regulatory framework to further AP research projects from …